CRISPR/Cas9 technology generated a G to A change at position 6307 (c.6307G>A) resulting in an alanine to threonine substitution at amino acid 2103 (p.A2103T), reported as p.A2105T. This single nucleotide substitution has been identified in human epilepsy. (J:324866)